Phase 1 Prostate Cancer Trial, RecruitingNCT06830850Sponsor: Atridia Pty Ltd.Condition: Prostate Cancer
Printed from Voxsanity (voxsanity.com.au) — NCT06830850 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
AI generated eligibility summary.
Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source.
How we use AI
Who might be able to join this trial:
People who are able to understand what the trial involves, including possible side effects, and who choose to take part voluntarily
People whose bone marrow and other major organs are functioning well enough (as determined by the trial site through testing)
People whose liver function test results meet the required levels (as determined by the trial site)
People who have prostate cancer that has spread to other parts of the body and is no longer responding to hormone-lowering treatments
Who may not be able to join:
People who are planning to receive any other cancer treatment during the trial
People who have received chemotherapy, targeted therapy, immunotherapy, a live or weakened vaccine, radiation therapy, or surgery within the 4 weeks before the trial's first dose
People with high blood pressure that is not well controlled (specifically, a top number above 150 or a bottom number above 100 on blood pressure readings, even while on blood pressure medication)
People who have difficulty swallowing, chronic diarrhoea, a bowel blockage, or any active gut or digestive condition that could affect how the trial medicine is absorbed or processed by the body
People with a known history of drug allergies or specific allergic conditions such as asthma, hives, or eczema
People who have had an active heart condition in the 6 months before the trial's first dose
People who have had another type of cancer within the 5 years before the trial's first dose
People who test positive for hepatitis B, hepatitis C, or syphilis, or who have a serious active infection that requires treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
GenesisCare North Shore (Oncology), Sydney, New South Wales
Sydney Adventist Hospital, Sydney, New South Wales
Cancer Research SA, Adelaide, South Australia
Southern Oncology Clinical Research Unit, Adelaide, South Australia
Icon Cancer Centre South Brisbane, Brisbane,
John Flynn Private Hospital, Brisbane,
Eastern Health (Box Hill Hospital), Melbourne,
Linear Clinical Research Ltd, Perth,
Macquarie University, Sydney,
MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy, Sydney,
Illawarra Shoalhaven Local Health District (Wollongong Hospital), Wollongong,
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Voxsanity
Clinical trials and treatments, explained plainly · voxsanity.com.au
Date:
To: My Doctor
Re: Clinical trial enquiry
I am writing to enquire about the following clinical trial which may be relevant to my care:
Trial: NCT06830850
Sponsor: Atridia Pty Ltd.
Phase: Phase 1
Status: Recruiting
Condition: Prostate Cancer
Trial contact: +61 02 9299 0433
More information: https://clinicaltrials.gov/study/NCT06830850
Eligibility summary (AI generated)
Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.
Who might be able to join this trial:
People who are able to understand what the trial involves, including possible side effects, and who choose to take part voluntarily
People whose bone marrow and other major organs are functioning well enough (as determined by the trial site through testing)
People whose liver function test results meet the required levels (as determined by the trial site)
People who have prostate cancer that has spread to other parts of the body and is no longer responding to hormone-lowering treatments
Who may not be able to join:
People who are planning to receive any other cancer treatment during the trial
People who have received chemotherapy, targeted therapy, immunotherapy, a live or weakened vaccine, radiation therapy, or surgery within the 4 weeks before the trial's first dose
People with high blood pressure that is not well controlled (specifically, a top number above 150 or a bottom number above 100 on blood pressure readings, even while on blood pressure medication)
People who have difficulty swallowing, chronic diarrhoea, a bowel blockage, or any active gut or digestive condition that could affect how the trial medicine is absorbed or processed by the body
People with a known history of drug allergies or specific allergic conditions such as asthma, hives, or eczema
People who have had an active heart condition in the 6 months before the trial's first dose
People who have had another type of cancer within the 5 years before the trial's first dose
People who test positive for hepatitis B, hepatitis C, or syphilis, or who have a serious active infection that requires treatment
Important: Always verify eligibility with the trial site directly before applying.
Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.
This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.
Trial details
Status
Recruiting
Phase
Phase 1
Sponsor
Atridia Pty Ltd.
Registry
ClinicalTrials.gov
Start date
15 June 2025
Est. completion
30 December 2026
Where this trial is recruiting
🇦🇺 Australia
11 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence and severity of adverse events, ECOG PS score, vital signs (pulse rate, respiratory rate, blood pressure, body temperature), ECG, clinical chemistry, hematology, urinalysis and physical examination
Can't join this trial?
Expanded access pathways
If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.